PUBLICATIONS

Recent Publications:

2023

Smets G, Gutermuth J, Grosber M, Baharlou S. Pulsed dye laser for facial erythema in Netherton syndrome. J Eur Acad Dermatol Venereol. 2023 Oct 4. doi: 10.1111/jdv.19547. 

De Brucker L, Seyler L, Leemans G, Gutermuth J, Grosber M. Acute generalized exanthematous pustulosis in a patient with COVID-19 infection.
J Eur Acad Dermatol Venereol. 2023 Apr 15. doi: 10.1111/jdv.19119. 

Gutermuth J, Grosber M, Pfaar O, Bergmann KC, Ring J. 111 years of allergen-immunotherapy: A long and successful history of the only available disease-modifier in allergic diseases. Allergol Select. 2022 Nov 21;6:248-258. doi: 10.5414/ALX02330E. eCollection 2022.

Hilhorst NT, Deprez E, Balak DMW, Van Geel N, Gutermuth J, Hoorens I, Lambert JLW. Initiating value-based healthcare in psoriasis: Proposing a value-based outcome set for daily clinical practice. J Eur Acad Dermatol Venereol. 2023 Mar;37(3):528-539. doi: 10.1111/jdv.18696. 

Charles N, Kortekaas Krohn I, Kocaturk E, Scheffel J, Altrichter S, Steinert C, Xiang Y, Gutermuth J, Reber L, Maurer M. Autoreactive IgE: from pathogenic role to therapeutic target. Allergy, 2023 Aug 9. doi: 10.1111/all.15843.

Kortekaas Krohn I*, Badloe FMS*, Herrmann N, Maintz L, De Vriese S, Ring J, CK-CARE study group, Bieber T, Gutermuth J. Immunoglobulin E autoantibodies in atopic dermatitis associates with Type 2 comorbidities and the atopic march.  Allergy, 2023 Jul 24. doi: 10.1111/all.15822.

Jadoul A, Huygen L, Leemans G, Grosber M, Kortekaas Krohn I, Gutermuth J. JAK1/2 pathway-specific treatment of disseminated granuloma annulare with baricitinib. J Eur Acad Dermatol Venereol. 2023 Mar 28. doi: 10.1111/jdv.19073.

Feleszko W, ……, Kortekaas Krohn I, ……, Tramper-Stranders G. EAACI statement on the pathogenesis, immunology, and immune-targeted management of the Multisystem Inflammatory Syndrome in Children (MIS-C) or Pediatric Inflammatory Multisystem Syndrome (PIMS). Pediatric Allergy and Immunology. Pediatr Allergy Immunol. 2023;34:e13900. doi:10.1111/pai.13900. 
 

2022

Silverberg JI, Adam DN, Zirwas M, Kalia S, Gutermuth J, Pinter A, Pink AE, Chiricozzi A, Barbarot S, Mark T, Tindberg AM, Weidinger S. Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis. Am J Clin Dermatol. 2022 Jul;23(4):547-559. doi: 10.1007/s40257-022-00702-2.

Piette Y, Reynaert V, Vanhaecke A, Bonroy C, Gutermuth J, Sulli A, Cutolo M, Smith V. Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases.
Autoimmun Rev. 2022 Jun;21(6):103087. doi: 10.1016/j.autrev.2022.103087.

Van den Steen E, Ramaekers D, Horlait M, Gutermuth J. Development of a patient-reported experience measure for chronic inflammatory skin diseases.
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):913-921. doi: 10.1111/jdv.17982.

Nguyen S, Van de Perre E, Velkeniers B, Pierret L, Gutermuth J, Grosber M. Resolution of idiopathic erythema gyratum repens with acitretin.
J Eur Acad Dermatol Venereol. 2022 Apr;36(4):e300-e302. doi: 10.1111/jdv.17851.

Gutermuth J, Pink AE, Worm M, Soldbro L, Bjerregård Øland C, Weidinger S. Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo-controlled, randomized, phase III clinical trial (ECZTRA 7).
Br J Dermatol. 2022 Mar;186(3):440-452. doi: 10.1111/bjd.20832. 

Badloe FMS, De Vriese S, De Bruyn Carlier T, Vandersichel E, Scheffel J, Maurer M, Ring J, Gutermuth J, Kortekaas Krohn I. A novel method for total IgE purification from human serum.  J Immunol. 2022 May 15;208(10):2436-2442. doi: 10.4049/jimmunol.2100497. 

Salimans L, Liberman K, Njemini R, Kortekaas Krohn I, Gutermuth J, Bautmans I. The effect of resistance exercise on the immune cell function in humans: a systematic review.  Exp Gerontol. 2022 Jul;164:111822. doi: 10.1016/j.exger.2022.111822.

Kortekaas Krohn I, Aerts JL, Breckpot K, Goyvaerts C, Knol E, Van Wijk F, Gutermuth J. T-cell subsets in the skin and their role in inflammatory skin disorders.  Allergy. 2022 Mar;77(3):827-842. doi: 10.1111/all.15104. 
 

2021

Peeters V, Janmohamed SR, Baharlou S, Gutermuth J, Willemsen R. Screening for Body Dysmorphic Disorder among Patients Seeking Dermatological and Cosmetic Care: A Cross-sectional Study. Acta Derm Venereol. 2021 Oct 19;101(10):adv00572. doi: 10.2340/actadv.v101.279.

De Bruyn Carlier T, Badloe FMS, Gutermuth J, Kortekaas Krohn I. Autoreactive T cells and their role in atopic dermatitis. J Autoimmun. 2021 Jun;120:102634. doi: 10.1016/j.jaut.2021.102634.

Vanderstraeten MCM, Gutermuth J, Grosber M. Contact anaphylaxis to poloxamer 188 and 407 in a periodontal gel. Contact Dermatitis. 2021 Mar 16. doi: 10.1111/cod.13834.

Kortekaas Krohn I. The emerging role of autoreactive antibodies in inflammatory skin diseases. J Eur Acad Dermatol Venereol. 2021 Apr;35(4):781-782. doi: 10.1111/jdv.17164. Not peer reviewed.

Smets G, Grosber M, Gutermuth J, Bravenboer B, Velkeniers B. Mesalazine-induced eosinophilic glossitis and hypereosinophilia in a patient with ulcerative colitis: a case report and review of literature. J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e462-e464. doi: 10.1111/jdv.17223. Epub 2021 Mar 25.

Janmohamed SR, Alsaad WK, Gutermuth J, Grosber M. Eosinophilic esophagitis due to red yeast rice (Monacoline K) in a dietary supplement for hypercholesterolemia.
Clin J Gastroenterol. 2021 Apr;14(2):407-409. doi: 10.1007/s12328-020-01309-y.

Saerens J, Gutermuth J, Janmohamed SR. An infant with localized vasoconstriction following topical propranolol exposure for infantile hemangioma. Pediatr Dermatol. 2021 Jan;38(1):263-264. doi: 10.1111/pde.14475.

Janmohamed SR, Grosber M, Eichenfield LF, Ring J, Gutermuth J. Medical algorithm: Diagnosis of atopic dermatitis in early childhood (part I). Allergy. 2021 Jan;76(1):403-406. doi: 10.1111/all.14638.

Janmohamed SR, Ring J, Eichenfield LF, Gutermuth J. Medical algorithm: Treatment of atopic dermatitis in early childhood (part II). Allergy. 2021 Jan;76(1):407-410. doi: 10.1111/all.14512.

Reynaert V, Grosber M, Tache A, Mana F, Buydens P, Lacor P, Gutermuth J. Oral tuberculosis in a patient with Crohn's disease on TNF-α blockers. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e236-e237. doi: 10.1111/jdv.16961.

Van Tendeloo E, Gutermuth J, Grosber M. Positive patch testing with omeprazole in Stevens-Johnson syndrome: a case report. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e74-e75. doi: 10.1111/jdv.16814.

2020

Badloe FMS, De Vriese S, Coolens K, Schmidt-Weber C., Ring J, Gutermuth J, Kortekaas Krohn I. IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis. Clin Transl Allergy 10, 34. 2020 Dec. Doi:10.1186/s13601-020-00338-7.

Sokolowska M.,et al. Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives – a report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy, 2020 Oct;75(10):2445-2476. doi: 10.1111/all.14462.

Gielen S, Janmohamed SR, Van Laethem A, Del Marmol V, Suppa M, Gutermuth J, Willemsen R. Hidradenitis suppurativa is associated with childhood and lifetime traumatic events: a case-control study. J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2877-2883. doi: 10.1111/jdv.16828.

Verheyden M, Grosber M, Gutermuth J, Velkeniers B. Relapsing symmetric livedo reticularis in a patient with COVID-19 infection. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e684-e686. doi: 10.1111/jdv.16773.

2019

Clarysse K, Pfaff CM, Marquardt Y, Huth L, Kortekaas Krohn I, Kluwig D, Lüscher B, Gutermuth J, Baron J.  JAK1/3-inhibition preserves epidermal morphology in full thickness 3D skin models of atopic dermatitis and psoriasis. J Eur Acad Dermatol Venereol. 2019 Feb;33(2):367-375. doi: 10.1111/jdv.15301.

Clarysse K, Grosber M, Ring J, Gutermuth J, Kivlahan C. Skin lesions, differential diagnosis and practical approach to potential survivors of torture.
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1232-1240. doi: 10.1111/jdv.15439.

Nguyen S, Grosber M, Gutermuth J. Acrokeratosis Can Be a Warning Sign of an Underlying Malignancy. Eur J Case Rep Intern Med. 2019 May 10;6(5):001108. doi: 10.12890/2019_001108.

Gutermuth J, Schmidt-Weber CB, Blank S. Supporting allergen-specific immunotherapy by inhibition of Janus kinases. Allergy. 2019 Sep;74(9):1814-1816. doi: 10.1111/all.13808.

Pierret L, Suppa M, Gandini S, Del Marmol V, Gutermuth J. Overview on vitamin D and sunbed use. J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:28-33. doi: 10.1111/jdv.15316.

2018

Clarysse K, Kivlahan C, Beyer I, Gutermuth J. Signs of physical abuse and neglect in the mature patient. Clin Dermatol. 2018 Mar - Apr;36(2):264-270. doi: 10.1016/j.clindermatol.2017.10.018. March 2018

Gerth van Wijk R, Eguiluz-Gracia I, Gayraud J, Gutermuth J, Hamelmann E, Heffler E, Popov TA, Schmid-Grendelmeier P, Tomazic PV, Tsilochristou O, Muelleneisen N. The roadmap for allergology in Europe: The subspecialty of allergology as "stop-over" on the way to a full specialty. An EAACI position statement. Allergy. 73(3):540-548. doi: 10.1111/all.13321. March 2018

Mostmans Y, Grosber M, De Coninck A, Peeters V, Ring J, Gutermuth J. Paraneoplastic systemic lupus erythematosus in association with oat cell tumour of the lung. J Eur Acad Dermatol Venereol. 32(1):e25-e26. doi: 10.1111/jdv.14473. January 2018